Jaguar Animal Health Reports an Availability of Canalevia-CA1 on Chewy for Chemotherapy-Induced Diarrhea in Dogs
Shots:
- Canalevia-CA1 (crofelemer delayed-release tablets), an US FDA conditionally authorized prescription medicine for the treatment of CID in dogs is now available on Chewy
- Chewy's award-winning customer service and fast and dependable shipping will give pet parents added simplicity, convenience, and support as they navigate cancer treatments for their dogs
- Canalevia-CA1 is a canine-specific formulation of Crofelemer & received Minor Use in a Major Species (MUMS) designation from the US FDA to treat CID in dogs. Jaguar is still gathering the strong proof of efficacy needed for a complete approval
Ref: Accesswire | Image: Jaguar Health
Related News:- Jaguar Health Submitted an IND Application to the US FDA for NP-300 to Treat Cholera-Related Diarrhea
Click here to read the full press release
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
